GPI Global Pricing Innovations

Quarterly GPI Values Awards – Q2

5 July 2021
Posted in

At GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.

Read More

GPI & MODEL N WEBINAR: Pricing from Hemisphere to Hemisphere

21 June 2021
Posted in

How you price your drugs is a big and important decision.

Read More

Quarterly GPI Values Awards – Q1

9 April 2021
Posted in

At GPI, our work is centred around our FOUR core values: Quality Matters, Sustainability, Authenticity and Collaboration. Every day, our amazing staff go above and beyond for our customers and strive to maintain the high quality standards and values that GPI stands for.

Read More

Innovative drugs manufactured in France will match highest price on European Market

11 March 2021
Posted in

The French state-industry drug framework agreement stipulates that innovative drugs manufactured in the country can have the same initial price as the highest one applied in Germany, the UK, Italy, or Spain The new 2021-24 framework agreement signed on Friday 5th March between France’s healthcare products committee CEPS and French pharma body Leem includes a…

Read More

Spain will require pricing & cost of treatment data for HTA submissions

3 December 2020
Posted in

Recently Spain’s medicines regulatory bodies announced the requirement of additional “economic evaluation” data for therapeutics positioning reports (IPTs) which is the equivalent of a Health Technology Assessment process in the country. This change is part of a revolution of the overall HTA process in 2021 which will include 12 steps, proposed to reduce the time…

Read More

Pfizer-BioNTech alliance declare success for vaccine against COVID-19

11 November 2020
Posted in

Pfizer and BioNTech have announced positive interim Phase III results for their mRNA-based COVID-19 vaccine, BNT162b2, suggesting that it is 90% effective in preventing infection.

Read More

Pharma industry concerned about recent PMPRB guidelines for IRP in Canada

28 October 2020
Posted in

Canada is due to adjust its international reference pricing (#IRP) basket of comparator countries come January, the 1st, 2021.

Read More

Germany’s GKV-SV targets to increase medicines’ spending ceiling by 4.6% in 2021

13 October 2020
Posted in

The spending adjustments have occurred to account for “the use of innovative drugs” (+4.6%), with a price reductions of -0.2% and a shift between service areas of community physicians and hospitals of +0.2%, according to the agreement dated 1 October.

Read More

White House blocks new FDA safety guidelines on COVID-19 vaccine approval

6 October 2020
Posted in

The new FDA guidelines were submitted for approval to the Office of Management and Budget on September 21, although they stalled with White House Chief of Staff, Mark Meadows.

Read More

Medicine Manufacturers Hit Hard by Latest French Healthcare Finance Reforms

2 October 2020
Posted in

Recently the French government has published its Social Security Finance Bill 2021 (PLFSS 2021), which covers the annual review of their health and social security expenditure.

Read More